APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $364,127 | +51.2% | 3,997 | +9.5% | 0.01% | +66.7% |
| Q1 2023 | $240,754 | +1.2% | 3,650 | -30.6% | 0.00% | -40.0% |
| Q2 2022 | $238,000 | -91.1% | 5,259 | -90.1% | 0.01% | -84.4% |
| Q1 2022 | $2,688,000 | -32.7% | 52,899 | -37.4% | 0.03% | +10.3% |
| Q4 2021 | $3,995,000 | +224.5% | 84,493 | +333.8% | 0.03% | +163.6% |
| Q2 2021 | $1,231,000 | +103.5% | 19,477 | +38.1% | 0.01% | +57.1% |
| Q1 2021 | $605,000 | -81.3% | 14,102 | -85.8% | 0.01% | -93.4% |
| Q2 2020 | $3,235,000 | +191.7% | 99,045 | +139.3% | 0.11% | +140.9% |
| Q1 2020 | $1,109,000 | -51.0% | 41,389 | -44.0% | 0.04% | +7.3% |
| Q4 2019 | $2,263,000 | – | 73,883 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |